Management of chemotherapy-related anaemia with low-dose recombinant human erythropoietin in patients with small cell lung cancer.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  European Journal of Cancer

• Publication date

  1997-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0959-8049(97)00264-5PMID 9616293
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease.

  1996cited by this paper
• Prediction of response to erythropoietin treatment in chronic anemia of cancer.

  1994cited by this paper
• Recombinant human erythropoietin and the anemia of cancer.

  1994cited by this paper
• Prediction of response to erythropoietin treatment in chronic anemia of cancer [see comments]

  1994cited by this paper
• Anaemia of chronic disease in rheumatoid arthritis: effect of the blunted response to erythropoietin and of interleukin 1 production by marrow macrophages.

  1992cited by this paper
• Changing patterns of care in the management of anemia.

  1992cited by this paper
• Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltration.

  1990cited by this paper
• Recombinant human erythropoietin activates a broad spectrum of progenitor cells.

  1990cited by this paper
• Recombinant human erythropoietin for patients with AIDS treated with zidovudine.

  1990cited by this paper
• Effects of recombinant erythropoietin on the concentration and cycling status of human marrow hematopoietic progenitor cells in vivo.

  1988cited by this paper
• Erythropoietin coming of age.

  1987cited by this paper
• Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.

  1987cited by this paper
• Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis.

  1986cited by this paper
• Role of chemotherapy in small cell lung cancer: a consensus report of the International Association for the Study of Lung Cancer workshop.

  1983cited by this paper
• Purification of human erythropoietin.

  1977cited by this paper

• [Management of chemotherapy-induced anemia in lung cancer].

  2015cites this paper
• Enhancement of Aerosol Cisplatin Chemotherapy with Gene Therapy Expressing ABC10 protein in Respiratory System

  2014cites this paper
• Inhaled gene therapy in lung cancer: proof-of-concept for nano-oncology and nanobiotechnology in the management of lung cancer.

  2013influential citation
• Intratumoral gene therapy versus intravenous gene therapy for distant metastasis control with 2-Diethylaminoethyl-Dextran Methyl Methacrylate Copolymer Non-Viral Vector–p53

  2013cites this paper
• “One-stop shop” spectral imaging for rapid on-site diagnosis of lung cancer: a future concept in nano-oncology

  2013cites this paper
• 2-diethylaminoethyl-dextran methyl methacrylate copolymer nonviral vector: still a long way toward the safety of aerosol gene therapy

  2013cites this paper
• Hematological Toxicity in Lung Cancer

  2011cites this paper
• Patterns of erythropoiesis-stimulating agent use for chemotherapy-induced anemia in lung cancer: results of a retrospective Hungarian real-life clinical data analysis

  2011influential citation
• Once-weekly epoetin beta (30,000 IU) in anemic patients with lung cancer receiving chemotherapy.

  2007cites this paper
• Role of epoetin in the management of anaemia in patients with lung cancer.

  2004cites this paper
• Toxicity of small cell lung cancer treatment.

  2004cites this paper
• A Phase II study of docetaxel and carboplatin in the treatment of non-small cell lung cancer.

  2001cites this paper
• Recombinant human erythropoietin (rhEPO) in the management of anemia and fatigue associated with solid tumors

  1998cites this paper